IL-9 Induces Differentiation of TH17 Cells and Enhances Function of Foxp3؉ Natural Regulatory T Cells

Total Page:16

File Type:pdf, Size:1020Kb

IL-9 Induces Differentiation of TH17 Cells and Enhances Function of Foxp3؉ Natural Regulatory T Cells IL-9 induces differentiation of TH17 cells and enhances function of FoxP3؉ natural regulatory T cells Wassim Elyamana, Elizabeth M. Bradshawa, Catherine Uyttenhoveb, Vale´ rie Dardalhona, Amit Awasthia, Jaime Imitolaa, Estelle Bettellia, Mohamed Oukkaa, Jacques van Snickb, Jean-Christophe Renauldb, Vijay K. Kuchrooa, and Samia J. Khourya,1 aCenter for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 and bLudwig Institute for Cancer Research and Experimental Medicine Unit, Universite´Catholique de Louvain, Brussels, Belgium Edited by Richard A. Flavell, Yale University School of Medicine, New Haven, CT, and approved March 31, 2009 (received for review December 11, 2008) The development of T helper (TH)17 and regulatory T (Treg) cells is ing large amounts of IL-10, but induce severe colitis and peripheral reciprocally regulated by cytokines. Transforming growth factor neuritis upon adoptive transfer into immune deficient hosts (14). ؉ ␤ (TGF)- alone induces FoxP3 Treg cells, but together with IL-6 or IL-21 Another recent report describes reprogramming of TH2 cells by induces TH17 cells. Here we demonstrate that IL-9 is a key molecule TGF-␤ to cells producing IL-9 and IL-10 (11), and these cells were that affects differentiation of TH17 cells and Treg function. IL-9 pre- also shown to have effector and not regulatory functions. These ␤ dominantly produced by TH17 cells, synergizes with TGF- 1 to differ- data suggest that IL-9/IL-10-producing T cells are not regulatory T ؉ entiate naïve CD4 T cells into TH17 cells, while IL-9 secretion by TH17 cells but effector T cells that induce tissue inflammation. However, cells is regulated by IL-23. Interestingly, IL-9 enhances the suppressive whether these effector functions are mediated by IL-9 and what role ؉ ؉ functions of FoxP3 CD4 Treg cells in vitro, and absence of IL-9 does IL-9 play in pathogenicity of this unique subset of T cells has signaling weakens the suppressive activity of nTregs in vivo, leading not been evaluated. to an increase in effector cells and worsening of experimental auto- In the present study, we show that TH17 cells produce large immune encephalomyelitis. The mechanism of IL-9 effects on TH17 quantities of IL-9 that act on both TH17 and Treg cells. In the and Tregs is through activation of STAT3 and STAT5 signaling. Our presence of TGF-␤, IL-9 differentiates naïve CD4ϩ T cells into findings highlight a role of IL-9 as a regulator of pathogenic versus TH17 cells. Paradoxically, IL-9 also acts on nTregs and enhances their protective mechanisms of immune responses. suppressive function in vitro and in vivo. Mice lacking IL-9 receptor (IL-9RϪ/Ϫ) exhibit a more severe course of experimental autoim- ͉ ͉ autoimmunity regulatory cells tolerance mune encephalomyelitis (EAE) and have a defect in the suppressive activity of Tregs. n the presence of antigen stimulation, naïve CD4ϩ T cells Iproliferate and differentiate into T helper type 1 (TH1) cells, TH2 Results cells, or interleukin-17 (IL-17)-producing T helper cells (TH17 cells) IL-9 Is Produced by TH17 Cells. TH17 cells produce several cytokines to exert specific effector functions. TH17 cells express the transcrip- including IL-17, IL-21, and IL-22 (2). We sought to determine the ␥ tion factor retinoic acid orphan receptor gamma (ROR- )t (1), additional cytokines that are secreted by TH17 cells. FACS-sorted participate in the control of extracellular pathogens, and have an naïve CD4ϩCD62LhiFoxP3Ϫ T cells isolated from FoxP3.GFP important role in human and experimental autoimmunity (2). TH17 ‘‘knock-in’’ (FoxP3.GFP.KI) reporter mice were differentiated into cells have been identified as major inducers of tissue inflammation TH1, TH2, and TH17 according to established protocols (Fig. S1A). and autoimmunity. Since exaggerated responses of TH1, TH2, and Inducible Tregs(iTregs) (7) were generated by activating TH17 cells can induce tissue inflammation, the maintenance of CD4ϩCD62LhiFoxP3Ϫ T cells in the presence of TGF-␤ (Fig. S1B), immune homeostasis and prevention of immunopathology is me- and nTregs were sorted from naïve FoxP3.GFP.KI mice based on in diated by subsets of T cells called regulatory T cells (Tregs). Treg cell vivo FoxP3 expression (Fig. S1C). Using multiplex bead-based differentiation and function are driven by the transcription factor Luminex technology, we identified IL-9 as a dominant cytokine forkhead box P3 (FoxP3) (3, 4), and they are closely related to the ␤ produced both by TH2 and TH17 cells (Fig. 1A). These data were generation of TH17 cells. Transforming growth factor (TGF)- 1 confirmed by quantitative Taqman PCR (Fig. 1A) and by flow induces the differentiation of T cells (5), whereas TGF-␤1in reg cytometry (Fig. 1B). Moreover, IL-9 was not detected in the combination with IL-6 (6, 7) or IL-21 (8) results in the differenti- supernatants of nT or iT (Fig. 1A), but IL-9R mRNA was ation of T 17 cells. regs reg H highly expressed by nT and not by iT (Fig. 1A). IL-9 is a T cell-derived factor preferentially expressed by T 2 regs regs H Naïve CD4ϩ T cells activated with plate-bound anti-CD3 and cells (9), although a previous study suggested that regulatory T cells anti-CD28 in the presence of recombinant mouse IL-9 had in- produce more IL-9 than TH2 cells (10); however this was not creased secretion of the TH2 (IL-4, IL-10, and IL-13), cytokines, confirmed in induced (iTregs) or natural (nTregs) (11). It is a ␥ pleiotropic cytokine that targets cells of the lymphoid, myeloid, and and at the same time down-regulated IFN (IFN)- and granulocyte- mast cell lineages, as well as lung epithelial cells. IL-9 activities are macrophage colony stimulation factor (GM-CSF) production (Fig. mediated by a specific IL-9 receptor chain that forms a het- IMMUNOLOGY erodimeric receptor with the common gamma chain (␥c) also Author contributions: W.E., C.U., J.I., J.V.S., J.-C.R., and S.J.K. designed research; W.E., involved in IL-2, 4, 7, 15, and 21 signaling. The IL-9 receptor and E.M.B., C.U., V.A.D., A.A., and J.V.S. performed research; C.U., E.B., M.O., J.V.S., J.-C.R., and ␥c associate with Janus kinase (JAK)1 and JAK3, respectively, and V.K.K. contributed new reagents/analytic tools; W.E., E.M.B., C.U., V.A.D., and J.V.S. ana- trigger the activation of STAT1, 3, and 5 (12, 13). Dysregulated IL-9 lyzed data; and W.E. wrote the paper. response in vitro can lead to autonomous cell growth and malignant The authors declare no conflict of interest. transformation of lymphoid cells associated with constitutive acti- This article is a PNAS Direct Submission. vation of the JAK/STAT pathway (12). We have recently described 1To whom correspondence should be addressed. E-mail: [email protected]. a subset of T cells that predominantly produces IL-9 together with This article contains supporting information online at www.pnas.org/cgi/content/full/ IL-10 and do not exhibit any regulatory properties despite produc- 0812530106/DCSupplemental. www.pnas.org͞cgi͞doi͞10.1073͞pnas.0812530106 PNAS ͉ August 4, 2009 ͉ vol. 106 ͉ no. 31 ͉ 12885–12890 Downloaded by guest on October 1, 2021 A B Th1 Th2 Th17 0.12 0.18 1.13 0.64 3.56 1.04 5 5 5 iTregs 10 10 10 nTregs 4 10 104 104 Th17 9 3 - 10 103 103 Th2 L I 2 Th1 10 102 102 Th0 0 0 0 67.6 32.1 84.2 13.9 82.8 12.6 0 50 100 150 200 250 300 350 400 450 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 0 1 2 3 4 5 6 7 8 9 0 102 103 104 105 0102 103 104 105 0102 103 104 105 IL-9 (pg/ml) IL-9 relative expression IL-9R relative expression IFN-γ IL-10 IL-17 TGF-β1 TGF-β1 C IL-4 IFN-γ 200 TGF-β 500 *** IL-21 400 IL-9 IL-6 300 100 IL-6 + TGF-β 200 IL-21 + TGF-β IL9 + TGF-β 100 No cytokine 0 0 0 100 200 300 0 100 200 300 400 500 no cytokine IL-9 no cytokin IL-9 pg/ml pg/ml ϩ hi Ϫ Fig. 1. TH17 cells produce IL-9. CD4 CD62L FoxP3/GFP T cells from FoxP3-GFP.KI mice were stimulated with anti-CD3 and anti-CD28 for 3–5 days in the presence of the corresponding cytokines. (A) IL-9 relative expression as determined by bead-based Luminex assay (left) and by quantitative RT-PCR (middle) and IL-9 ϩ hi receptor relative expression (right) in TH0, TH1, TH2, TH17, nTregs, and iTregs.(B) Intracellular staining of cytokines in naïve CD4 CD62L T cells from B6 mice sorted ϩ by flow cytometry and cultured for 4 days in TH1, TH2, or TH17 conditions. (C) Effects of IL-9 on the production of IL-4, IFN-␥, and TGF-␤1 by naïve CD4 T cells as measured by bead-based Luminex assay. For TGF-␤1 assay, supernatants were ‘‘acid-treated’’ followed by bead-based Luminex assay. Effect of IL-9 on TGF-␤1 expression in T cells was also measured by quantitative Taqman PCR. 1C and Fig. S2). Interestingly, cells exposed to IL-9 produce IL-9 might normally contribute to TH17 differentiation even when significant amounts of TGF-␤1 and this was confirmed by Taqman TH17 cells were differentiated by other cytokine cocktails (TGF-␤ PCR (Fig.
Recommended publications
  • Regulatory T Cells Promote a Protective Th17-Associated Immune Response to Intestinal Bacterial Infection with C
    ARTICLES nature publishing group Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium Z Wang1, C Friedrich1, SC Hagemann1, WH Korte1, N Goharani1, S Cording2, G Eberl2, T Sparwasser1,3 and M Lochner1,3 Intestinal infection with the mouse pathogen Citrobacter rodentium induces a strong local Th17 response in the colon. Although this inflammatory immune response helps to clear the pathogen, it also induces inflammation-associated pathology in the gut and thus, has to be tightly controlled. In this project, we therefore studied the impact of Foxp3 þ regulatory T cells (Treg) on the infectious and inflammatory processes elicited by the bacterial pathogen C. rodentium. Surprisingly, we found that depletion of Treg by diphtheria toxin in the Foxp3DTR (DEREG) mouse model resulted in impaired bacterial clearance in the colon, exacerbated body weight loss, and increased systemic dissemination of bacteria. Consistent with the enhanced susceptibility to infection, we found that the colonic Th17-associated T-cell response was impaired in Treg-depleted mice, suggesting that the presence of Treg is crucial for the establishment of a functional Th17 response after the infection in the gut. As a consequence of the impaired Th17 response, we also observed less inflammation-associated pathology in the colons of Treg-depleted mice. Interestingly, anti-interleukin (IL)-2 treatment of infected Treg-depleted mice restored Th17 induction, indicating that Treg support the induction of a protective
    [Show full text]
  • Regulation of Type 17 Helper T-Cell Function by Nitric Oxide During Inflammation
    Regulation of type 17 helper T-cell function by nitric oxide during inflammation Wanda Niedbalaa,1, Jose C. Alves-Filhoa,b,1, Sandra Y. Fukadaa,c,1, Silvio Manfredo Vieirab, Akio Mitania,d, Fabiane Sonegoa, Ananda Mirchandania, Daniele C. Nascimentoa, Fernando Q. Cunhab, and Foo Y. Liewa,2 aInstitute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow G12 8TA, Scotland; bDepartment of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo,14049-900, Ribeirão Preto, Brazil; cDepartment of Physics and Chemistry, Faculty of Pharmaceutical Sciences, University of São Paulo, 14040-903, Ribeirão Preto, Brazil; and dDepartment of Periodontology, School of Dentistry, Aichi Gakuin University, Nagoya, 464-8651 Japan Edited by Yoichiro Iwakura, Institute of Medical Science, University of Tokyo, Tokyo, Japan, and accepted by the Editorial Board April 19, 2011 (received for review January 13, 2011) − Type 17 helper T (Th17) cells are implicated in the pathogenesis suppressed the proliferation of freshly purified CD4+CD25 many of human autoimmune diseases. Development of Th17 can effector cells in vitro and ameliorated the effector T cell-mediated be enhanced by the activation of aryl hydrocarbon receptor (AHR) colitis and collagen-induced arthritis in the mouse in an IL-10– whose ligands include the environmental pollutant dioxin, poten- dependent manner. Both Th1 and Treg cells are pivotal to auto- tially linking environmental factors to the increased prevalence of immune diseases, indicating that NO may be a key player in mod- autoimmune disease. We report here that nitric oxide (NO) can ulating inflammatory disease. suppress the proliferation and function of polarized murine and Th17 cell differentiation is dependent on IL-6, IL-1, and TGF- β (with potential species-specific differences) and is enhanced human Th17 cells.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Cytokine Nomenclature
    RayBiotech, Inc. The protein array pioneer company Cytokine Nomenclature Cytokine Name Official Full Name Genbank Related Names Symbol 4-1BB TNFRSF Tumor necrosis factor NP_001552 CD137, ILA, 4-1BB ligand receptor 9 receptor superfamily .2. member 9 6Ckine CCL21 6-Cysteine Chemokine NM_002989 Small-inducible cytokine A21, Beta chemokine exodus-2, Secondary lymphoid-tissue chemokine, SLC, SCYA21 ACE ACE Angiotensin-converting NP_000780 CD143, DCP, DCP1 enzyme .1. NP_690043 .1. ACE-2 ACE2 Angiotensin-converting NP_068576 ACE-related carboxypeptidase, enzyme 2 .1 Angiotensin-converting enzyme homolog ACTH ACTH Adrenocorticotropic NP_000930 POMC, Pro-opiomelanocortin, hormone .1. Corticotropin-lipotropin, NPP, NP_001030 Melanotropin gamma, Gamma- 333.1 MSH, Potential peptide, Corticotropin, Melanotropin alpha, Alpha-MSH, Corticotropin-like intermediary peptide, CLIP, Lipotropin beta, Beta-LPH, Lipotropin gamma, Gamma-LPH, Melanotropin beta, Beta-MSH, Beta-endorphin, Met-enkephalin ACTHR ACTHR Adrenocorticotropic NP_000520 Melanocortin receptor 2, MC2-R hormone receptor .1 Activin A INHBA Activin A NM_002192 Activin beta-A chain, Erythroid differentiation protein, EDF, INHBA Activin B INHBB Activin B NM_002193 Inhibin beta B chain, Activin beta-B chain Activin C INHBC Activin C NM005538 Inhibin, beta C Activin RIA ACVR1 Activin receptor type-1 NM_001105 Activin receptor type I, ACTR-I, Serine/threonine-protein kinase receptor R1, SKR1, Activin receptor-like kinase 2, ALK-2, TGF-B superfamily receptor type I, TSR-I, ACVRLK2 Activin RIB ACVR1B
    [Show full text]
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation
    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
    [Show full text]
  • Type 2 Immunity in Tissue Repair and Fibrosis
    REVIEWS Type 2 immunity in tissue repair and fibrosis Richard L. Gieseck III1, Mark S. Wilson2 and Thomas A. Wynn1 Abstract | Type 2 immunity is characterized by the production of IL‑4, IL‑5, IL‑9 and IL‑13, and this immune response is commonly observed in tissues during allergic inflammation or infection with helminth parasites. However, many of the key cell types associated with type 2 immune responses — including T helper 2 cells, eosinophils, mast cells, basophils, type 2 innate lymphoid cells and IL‑4- and IL‑13‑activated macrophages — also regulate tissue repair following injury. Indeed, these cell populations engage in crucial protective activity by reducing tissue inflammation and activating important tissue-regenerative mechanisms. Nevertheless, when type 2 cytokine-mediated repair processes become chronic, over-exuberant or dysregulated, they can also contribute to the development of pathological fibrosis in many different organ systems. In this Review, we discuss the mechanisms by which type 2 immunity contributes to tissue regeneration and fibrosis following injury. Type 2 immunity is characterized by increased pro‑ disorders remain unclear, although persistent activation duction of the cytokines IL‑4, IL‑5, IL‑9 and IL‑13 of tissue repair pathways is a major contributing mech‑ (REF. 1) . The T helper 1 (TH1) and TH2 paradigm was anism in most cases. In this Review, we provide a brief first described approximately three decades ago2, and overview of fibrotic diseases that have been linked to for many of the intervening years, type 2 immunity activation of type 2 immunity, discuss the various mech‑ was largely considered as a simple counter-­regulatory anisms that contribute to the initiation and maintenance mechanism controlling type 1 immunity3 (BOX 1).
    [Show full text]
  • Review Article Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
    Hindawi Publishing Corporation Clinical and Developmental Immunology Volume 2013, Article ID 968549, 13 pages http://dx.doi.org/10.1155/2013/968549 Review Article Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases Ning Qu,1 Mingli Xu,2 Izuru Mizoguchi,3 Jun-ichi Furusawa,3 Kotaro Kaneko,3 Kazunori Watanabe,3 Junichiro Mizuguchi,4 Masahiro Itoh,1 Yutaka Kawakami,2 and Takayuki Yoshimoto3 1 DepartmentofAnatomy,TokyoMedicalUniversity,6-1-1Shinjuku,Shinjuku-ku,Tokyo160-8402,Japan 2 Division of Cellular Signaling, Institute for Advanced Medical Research School of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan 3 Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo160-8402, Japan 4 Department of Immunology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan Correspondence should be addressed to Takayuki Yoshimoto; [email protected] Received 12 April 2013; Accepted 25 June 2013 Academic Editor: William O’Connor Jr. Copyright © 2013 Ning Qu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. T-helper 17 (Th17) cells are characterized by producing interleukin-17 (IL-17, also called IL-17A), IL-17F, IL-21, and IL-22 and potentially TNF- and IL-6 upon certain stimulation. IL-23, which promotes Th17 cell development, as well as IL-17 and IL-22 produced by the Th17 cells plays essential roles in various inflammatory diseases, such as experimental autoimmune encephalomyelitis, rheumatoid arthritis, colitis, and Concanavalin A-induced hepatitis.
    [Show full text]
  • HP Turns 17: T Helper 17 Cell Response During Hypersensitivity
    University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 5-2012 HP Turns 17: T helper 17 cell response during hypersensitivity pneumonitis (HP) and factors controlling it Hossam Abdelsamed University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Medical Immunology Commons, Medical Microbiology Commons, and the Medical Molecular Biology Commons Recommended Citation Abdelsamed, Hossam , "HP Turns 17: T helper 17 cell response during hypersensitivity pneumonitis (HP) and factors controlling it" (2012). Theses and Dissertations (ETD). Paper 6. http://dx.doi.org/10.21007/etd.cghs.2012.0002. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact [email protected]. HP Turns 17: T helper 17 cell response during hypersensitivity pneumonitis (HP) and factors controlling it Document Type Dissertation Degree Name Doctor of Philosophy (Medical Science) Program Microbiology, Molecular Biology and Biochemistry Track Microbial Pathogenesis, Immunology, and Inflammation Research Advisor Elizabeth A. Fitzpatrick, Ph.D. Committee David D. Brand, Ph.D. Fabio C. Re, Ph.D. Susan E. Senogles, Ph.D. Christopher M. Waters, Ph.D. DOI 10.21007/etd.cghs.2012.0002 This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/6 HP TURNS 17: T HELPER 17 CELL RESPONSE DURING HYPERSENSITIVITY PNEUMONITIS (HP) AND FACTORS CONTROLLING IT A Dissertation Presented for The Graduate Studies Council The University of Tennessee Health Science Center In Partial Fulfillment Of the Requirements for the Degree Doctor of Philosophy From The University of Tennessee By Hossam Abdelsamed May 2012 Portions of Chapter 3 © 2012 by BioMed Central Ltd.
    [Show full text]
  • Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency
    Practice parameter Practice parameter for the diagnosis and management of primary immunodeficiency Francisco A. Bonilla, MD, PhD, David A. Khan, MD, Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD, David I. Bernstein, MD, Joann Blessing-Moore, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Chief Editor: Francisco A. Bonilla, MD, PhD Co-Editor: David A. Khan, MD Members of the Joint Task Force on Practice Parameters: David I. Bernstein, MD, Joann Blessing-Moore, MD, David Khan, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Primary Immunodeficiency Workgroup: Chairman: Francisco A. Bonilla, MD, PhD Members: Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD GlaxoSmithKline, Merck, and Aerocrine; has received payment for lectures from Genentech/ These parameters were developed by the Joint Task Force on Practice Parameters, representing Novartis, GlaxoSmithKline, and Merck; and has received research support from Genentech/ the American Academy of Allergy, Asthma & Immunology; the American College of Novartis and Merck.
    [Show full text]
  • Genetic Controls of Th17 Cell Differentiation and Plasticity
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 43, No. 1, 1-6, January 2011 Genetic controls of Th17 cell differentiation and plasticity Chen Dong1 Th cell differentiation is instructed by distinct environmental cytokines, which signals through Department of Immunology and Center for Inflammation and Cancer STAT or other inducible but generally ubiquitous MD Anderson Cancer Center transcription factors. These factors then upregulate Houston, TX, USA the expression of lineage-specific transcription fa- 1Correspondence: Tel, 1-713-563-3203; ctors, which function not only to promote its own Fax, 1-713-563-0604; E-mail, [email protected] lineage differentiation but also to inhibit the al- DOI 10.3858/emm.2011.43.1.007 ternate differentiation pathways. There are exten- sive cross-regulations of lineage-determining trans- cription factors. Moreover, there is growing evi- Accepted 22 December 2010 Available Online 23 December 2010 dence that Th cell lineage commitment can be plastic in certain circumstances. Here, I summarize Abbreviation: Th cells, T helper cells our current understanding on the genetic controls of Th17 cell lineage differentiation and discuss on the evidence and mechanisms underlying their Abstract plasticity. CD4+ T lymphocytes play a major role in regulation of adaptive immunity. Upon activation, naïve T cells dif- Transcriptional control of Th17 cell ferentiate into different functional subsets. In addition differentiation to the classical Th1 and Th2 cells, several novel effector T cell subsets have been recently identified, including Th17 cell differentiation can be induced by the Th17 cells. There has been rapid progress in character- combination of TGFβ and IL-6 or IL-21 (Dong, izing the development and function of Th17 cells.
    [Show full text]
  • Down Syndrome Acute Lymphoblastic Leukemia, a Highly Heterogeneous
    Hertzberg, L; Vendramini, E; Ganmore, I; Cazzaniga, G; Schmitz, M; Chalker, J; Shiloh, R; Iacobucci, I; Shochat, C; Zeligson, S; Cario, G; Stanulla, M; Strehl, S; Russell, L J; Harrison, C J; Bornhauser, B; Yoda, A; Rechavi, G; Bercovich, D; Borkhardt, A; Kempski, H; te Kronnie, G; Bourquin, J P; Domany, E; Izraeli, S (2010). Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood, 115(5):1006-1017. University of Zurich Postprint available at: Zurich Open Repository and Archive http://www.zora.uzh.ch Posted at the Zurich Open Repository and Archive, University of Zurich. http://www.zora.uzh.ch Winterthurerstr. 190 Originally published at: CH-8057 Zurich Blood 2010, 115(5):1006-1017. http://www.zora.uzh.ch Year: 2010 Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group Hertzberg, L; Vendramini, E; Ganmore, I; Cazzaniga, G; Schmitz, M; Chalker, J; Shiloh, R; Iacobucci, I; Shochat, C; Zeligson, S; Cario, G; Stanulla, M; Strehl, S; Russell, L J; Harrison, C J; Bornhauser, B; Yoda, A; Rechavi, G; Bercovich, D; Borkhardt, A; Kempski, H; te Kronnie, G; Bourquin, J P; Domany, E; Izraeli, S Hertzberg, L; Vendramini, E; Ganmore, I; Cazzaniga, G; Schmitz, M; Chalker, J; Shiloh, R; Iacobucci, I; Shochat, C; Zeligson, S; Cario, G; Stanulla, M; Strehl, S; Russell, L J; Harrison, C J; Bornhauser, B; Yoda, A; Rechavi, G; Bercovich, D; Borkhardt, A; Kempski, H; te Kronnie, G; Bourquin, J P; Domany, E; Izraeli, S (2010).
    [Show full text]
  • Innate Lymphoid Cells: Transcriptional Profiles and Cytokine Developmental Requirements Michelle Lauren Robinette Washington University in St
    Washington University in St. Louis Washington University Open Scholarship Arts & Sciences Electronic Theses and Dissertations Arts & Sciences Spring 5-15-2018 Innate Lymphoid Cells: Transcriptional Profiles and Cytokine Developmental Requirements Michelle Lauren Robinette Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds Part of the Allergy and Immunology Commons, Immunology and Infectious Disease Commons, and the Medical Immunology Commons Recommended Citation Robinette, Michelle Lauren, "Innate Lymphoid Cells: Transcriptional Profiles and Cytokine Developmental Requirements" (2018). Arts & Sciences Electronic Theses and Dissertations. 1571. https://openscholarship.wustl.edu/art_sci_etds/1571 This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology and Biomedical Sciences Immunology Dissertation Examination Committee: Marco Colonna, Chair Maxim Artyomov Takeshi Egawa Gwen Randolph Wayne Yokoyama Innate Lymphoid Cells: Transcriptional Profiles and Cytokine Developmental Requirements by Michelle Lauren Robinette A dissertation presented to The Graduate School of Washington University in partial fulfillment of the requirements
    [Show full text]